Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Imarc Group
www.imarcgroup.com/
Kanika Sharma
sales@imarcgroup.com
8130434268

Bookmark and Share
Japan Ai in Drug Discovery Market Size, Growth, and Trends Forecast 2026-2034
The Japan AI in drug discovery market size reached USD 131.06 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 796.09 Million by 2034, exhibiting a growth rate (CAGR) of 22.20% during 2026-2034.

BriefingWire.com, 2/18/2026 - Japan Ai in Drug Discovery Market Size and Growth Overview (2026-2034)

Market Size in 2025: USD 131.06 Million

Market Forecast in 2034: USD 796.09 Million

Market Growth Rate 2026-2034: 22.20%

According to the latest report by IMARC Group, the Japan AI in drug discovery market size reached USD 131.06 million in 2025. Looking forward, IMARC Group expects the market to reach USD 796.09 million by 2034, exhibiting a growth rate (CAGR) of 22.20% during 2026-2034.

Request a Free Sample PDF for Detailed Market Insights: https://www.imarcgroup.com/japan-ai-in-drug-discovery-market/requestsample

Japan AI in Drug Discovery Market Trends & Drivers

Japan is witnessing transformative advancements in AI-powered drug discovery driven by the deployment of sovereign AI infrastructure specifically designed for pharmaceutical research. Leading Japanese pharmaceutical companies are harnessing advanced high-performance computing platforms to build sophisticated AI models for drug discovery applications. These companies utilize specialized platforms that enable drug discovery researchers to develop and deploy AI models for generating biological intelligence from biomolecular data.

The integration of quantum computing with artificial intelligence represents a frontier technology advancement that is reshaping drug discovery methodologies in Japan. Pharmaceutical divisions of major Japanese corporations are pioneering the application of quantum-hybrid computational workflows to enhance the generative capabilities of large language models, specifically for molecular design and drug candidate identification.

Japan AI in Drug Discovery Industry Segmentation

The report has segmented the market into the following categories:

Breakup by Offering:

Software

Services

Breakup by Application:

Preclinical Testing

Drug Optimization and Repurposing

Target Identification

Candidate Screening

Others

Breakup by Therapeutic Area:

Oncology

Neurodegenerative Diseases

Cardiovascular Diseases

Metabolic Diseases

Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs)

Research Centers and Academic Institutes

Breakup by Region:

Kanto Region

Kinki Region

Central/Chubu Region

Kyushu-Okinawa Region

Tohoku Region

Chugoku Region

Hokkaido Region

Shikoku Region

Request a Customized Version of This Report for Deeper Insights: https://www.imarcgroup.com/request?type=report&id=44456&flag=E

Competitive Landscape:

The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.

Key highlights of the report:

Market Performance (2020-2025)

Market Outlook (2026-2034)

COVID-19 Impact on the Market

Porter's Five Forces Analysis

Strategic Recommendations

Historical, Current, and Future Market Trends

Market Drivers and Success Factors

SWOT Analysis

Structure of the Market

Value Chain Analysis

Comprehensive Mapping of the Competitive Landscape

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please l

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.